Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. METHODS: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. RESULTS: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). CONCLUSIONS: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial, 30 which randomly assigned 128 ICD patients with a history of ventricular arrhythmia and myocardial infarction to ablation or usual care, arrhythmia recurrence was significantly decreased from 33% to 12% with ablation.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [30]
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Marchlinski, F. E., Callans, D. J., Gottlieb, C. D., & Zado, E. (2000) · Circulation · doi:10.1161/01.cir.101.11.1288 · Cited by 1,220
Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 597
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Guiraudon, G., Fontaine, G., Frank, R., Escande, G., Etievent, P., & Cabrol, C. (1978) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62923-2 · Cited by 404
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S. C., Klingenheben, T., Mauss, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 376
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Research works printed but not linked: 1
- Stevenson WG, 2005, Curr Opin Cardiol, 20, 42
Cited by
Items 201–300 of 964
Turagam, M. K., Vuddanda, V. L. K., Koerber, S. M., Garg, J., Yarlagadda, B., Dar, T. A., Aryana, A., Biase, L. D., Natale, A., & Lakkireddy, D. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0477-1 · Cited by 31
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12264 · Cited by 31
Mathew, S., Fink, T., Feickert, S., Inaba, O., Hashiguchi, N., Schlüter, M., Wohlmuth, P., Wißner, E., Tilz, R. R., Heeger, C.-H. H., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01902-2 · Cited by 31
John, R. M., Connell, J., Termin, P. L., Houde‐Walter, H., EBERL, G., STOHLMAN, K. M., & Curley, M. G. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12307 · Cited by 31
Field, M. E., Gold, M. R., Reynolds, M. R., Goldstein, L. J., Lee, S. H., Kalsekar, I. D., COPLAN, P. M., Wong, C., Khanna, R., & Winterfield, J. R. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14324 · Cited by 31
Self-citationAn Entirely Subcutaneous Implantable Cardioverter–Defibrillator
Buga, L., Abdellah, A. T., & Cleland, J. G. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1008499 · Cited by 31
Ventricular arrhythmias in acute coronary syndromes—mechanisms and management
Thomas, D., Jex, N., & Thornley, A. R. (2017) · Continuing Cardiology Education · doi:10.1002/cce2.51 · Cited by 40
Maskoun, W., Saad, M. S., Abualsuod, A. M., Nairooz, R. S., & Miller, J. M. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.127 · Cited by 31
Zhou, S., AbdelWahab, A. M., Sapp, J. L., Warren, J. W., & Horáček, B. M. (2018) · Annals of Biomedical Engineering · doi:10.1007/s10439-018-02168-y · Cited by 33
Darma, A., Bertagnolli, L., Dinov, B., Torri, F., Shamloo, A. S., Lurz, J. A., Dagres, N., Husser-Bollmann, D., Bollmann, A., Hindricks, G., et al. (2020) · EP Europace · doi:10.1093/europace/euaa189 · Cited by 29
Roujol, S., Anter, E., Josephson, M. E., & Nezafat, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078852 · Cited by 29
“cantly reduces and delays the incidence of implantable cardioverter-defibrillator therapy in post myocardial infarction patients [1,2].”
BackgroundSelf-citationTeam Management of the Ventricular Tachycardia Patient
Tang, P., Do, D. H., Li, A. C., & Boyle, N. G. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.37.2 · Cited by 29
Inactivation of human glutamate dehydrogenase by aluminum
Yang, S.-J., Huh, J. W., Lee, J. E., Choi, S. Y., Kim, T. U., & Cho, S.-W. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3298-y · Cited by 32
JCS / JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias
Iwasaki, Y., Noda, T., Akao, M., Fujino, T., Hirano, T., Inoue, K., Kusano, K., Nagai, T., Satomi, K., Shinohara, T., et al. (2025) · Journal of Arrhythmia · doi:10.1002/joa3.70033 · Cited by 29
Tung, R. H., Nakahara, S., Ramírez, R. J., Gui, D., Magyar, C. E., Lai, C. K., Fishbein, M. C., & Shivkumar, K. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.10.044 · Cited by 28
Baldinger, S. H., Kumar, S., Romero, J. E., Fujii, A., Epstein, L. M., Michaud, G. F., John, R. M., Tedrow, U. B., & Stevenson, W. G. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13127 · Cited by 28
Ventricular Tachycardia in Structural Heart Disease
Lopez, E. M., & Malhotra, R. (2019) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2019.100801 · Cited by 29
Proietti, R., Dowd, R. P., Lim, V. G., Yusuf, S., Panikker, S., Hayat, S. A., Osman, F., Patel, K., Salim, H., Aldhoon, B., et al. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00918-4 · Cited by 28
Nedios, S., Darma, A., Stevanello, C., Richter, S., Doering, M., Rolf, S., Sommer, P., Hindricks, G., Bollmann, A., & Arya, A. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.07.034 · Cited by 28
Ventricular tachycardia in ischemic heart disease substrates
Ajijola, O. A., Tung, R. H., & Shivkumar, K. (2014) · Indian Heart Journal · doi:10.1016/j.ihj.2013.12.039 · Cited by 28
Imaging-guided Ventricular Tachycardia Ablation
Piers, S. R. D., & Zeppenfeld, K. (2013) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2013.2.2.128 · Cited by 28
Epicardial Ablation for Ventricular Tachycardia in Chronic Chagas Heart Disease
Scanavacca, M. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140082 · Cited by 28
The Role of Electrophysiology Study in Risk Stratification of Sudden Cardiac Death
Thomas, K. E., & Josephson, M. E. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.05.001 · Cited by 27
Self-citationMukherjee, R. K., Roujol, S., Chubb, H., Harrison, J., Williams, S. E., Whitaker, J., O’Neill, L., Silberbauer, J., Neji, R., Schneider, R., et al. (2017) · EP Europace · doi:10.1093/europace/eux341 · Cited by 27
Dusi, V., GORNBEIN, J. A., Do, D. H., Sorg, J. M., Khakpour, H., Krokhaleva, Y., Ajijola, O. A., Macias, C., Bradfield, J. S., Buch, E. F., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018371 · Cited by 27
“Clinical presentation (elective/ urgent/emergent), n§ 108/261/9 (29, 68, 2) 18/46/3 (27, 68, 4) 90/215/6 (29/68/2) 0.”
Kahle, A., Jungen, C., Alken, F., Scherschel, K., Willems, S., Pürerfellner, H., Chen, S., Eckardt, L., & Meyer, C. G. (2021) · EP Europace · doi:10.1093/europace/euab274 · Cited by 28
Robotic catheter ablation of left ventricular tachycardia: initial experience
Valderrábano, M., Dave, A. S., Báez-Escudero, J. L., & Rami, T. G. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.07.032 · Cited by 27
“Four patients underwent focal LV ablation of idiopathic outflow VT (1) or symptomatic, frequent premature ventricular complexes (3).”
BackgroundSpatiotemporal Frequency Analysis of Ventricular Fibrillation in Explanted Human Hearts
Umapathy, K., Massé, S., Sevaptsidis, E., Asta, J. A., Krishnan, S., & Nanthakumar, K. (2008) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2008.2006031 · Cited by 27
“Empiric delivery of RF ablation therapy has been proposed for human VT and VF [26].”
BackgroundHeart Failure and Sudden Cardiac Death
Saour, B., Smith, B., & Yancy, C. W. (2017) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.07.010 · Cited by 30
Briceno, D. F., Gupta, T., Romero, J. E., Kolte, D. S., Khera, S., Villablanca, P. A., Tran, A., Mohanty, S., Trivedi, C. G., Mohanty, P. K., et al. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13452 · Cited by 27
Pauriah, M., Cismaru, G. L., Magnin‐Poull, I., Andronache, M., Sellal, J., Schwartz, J., Brembilla-Perrot, B., Sadoul, N., Aliot, E., & de Chillou, C. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000261 · Cited by 29
Protas, L., Dun, W., Jia, Z., Lü, J., Bucchi, A., Kumari, S., Chen, M., Cohen, I. S., Rosen, M. R., Entcheva, E. G., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn290 · Cited by 27
“human subjects with ischaemic heart disease, Reddy et al.(28) demonstrated they could identify sites of fragmented electrogram configuration, reflecting abnormal conduction, and ablate these to reduce the number of ICD shocks (for lethal arrhythmias) by about 70%.”
BackgroundSivagangabalan, G., Pouliopoulos, J., Huang, K., Lu, J., Barry, M. A., Thiagalingam, A., Ross, D. L., Thomas, S. P., & Kovoor, P. (2008) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.799619 · Cited by 27
A review of the safety aspects of radio frequency ablation
Bhaskaran, A. P., CHIK, W. W. B., Thomas, S. P., Kovoor, P., & Thiagalingam, A. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.04.011 · Cited by 30
“Prophylactic, scar VT ablations are those undertaken after the first arrhythmia as opposed to ablation after recurrent ventricular arrhythmias [63,64].”
BackgroundLi, A. C., Buch, E. F., Boyle, N. G., Shivkumar, K., & Bradfield, J. S. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.09.007 · Cited by 26
“001 Reason Limited mapping—adhesions NA 4 Access abandoned—adhesions NA 5 Bleeding 4 2 Induced VT, median (IQR) 1 (2) 1.”
BackgroundPothineni, N. V. K., Deshmukh, A. J., Padmanabhan, D., Kovelamudi, S., Patel, N., Badheka, A. O., Mulpuru, S. K., Paydak, H., & Noseworthy, P. A. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.116 · Cited by 26
“[5] RCT 40 SMASH VT [6] RCT 64”
BackgroundMethodQian, P. C., Silva, K. D., Kumar, S., Nadri, F., Samanta, R., Bhaskaran, A. P., Ross, D. L., Sivagangabalan, G., Cooper, M. J., Kizana, E., et al. (2018) · EP Europace · doi:10.1093/europace/euy057 · Cited by 26
“Catheter ablation can be curative in idiopathic VT and reduce VT burden and appropriate ICD shocks in patients with ischaemic cardiomyopathy[3].”
BackgroundVerma, A., Essebag, V., Neužil, P., Dyrda, K., Balt, J. C., Dinov, B., Darma, A., Arya, A., Sacher, F., Reddy, V. Y., et al. (2024) · EP Europace · doi:10.1093/europace/euae076 · Cited by 25
Self-citationBhagirath, P., Campos, F. O., Costa, C. M., Wilde, A. A. M., Prassl, A. J., Neic, A., Plank, G., Rinaldi, C. A., Götte, M., & Bishop, M. J. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.05.021 · Cited by 25
“Introduction Catheter ablation for ventricular tachycardia (VT) has been proven to significantly reduce therapy and shocks from implantable cardioverter-defibrillators (ICDs).(1) However, current guidelines for patients with an ischemic cardiomyopathy recommend catheter ablation only in case of recurrent ICD shocks du…”
Repolarization Heterogeneity in Human Post-Infarct Ventricular Tachycardia
Callans, D. J., & Donahue, J. K. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.03.002 · Cited by 25
Early Catheter Ablation Versus Initial Medical Therapy for Ventricular Tachycardia Storm
Huang, K., Bennett, R. G., Campbell, T. G., Lee, V., Turnbull, S., CHIK, W. W. B., Elsokkari, I., Hallani, H., Dieleman, J. M., Kruit, N., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.122.011129 · Cited by 25
Ávila, P., David, E. P., Izquierdo, M., González, A. M. R., Sánchez‐Gómez, J. M., Ledesma‐Carbayo, M. J., López-Lereu, M. P., Loughlin, G., Monmeneu, J. V., González‐Torrecilla, E., et al. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.07.006 · Cited by 25
Akca, F., Önsesveren, I., Jordaens, L. J. L. M., & Szili‐Törok, T. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-011-9645-2 · Cited by 25
“Treatment of ventricular tachycardia (VT) has gone through great improvements in recent years [1–3].”
BackgroundMinimal and deep sedation during ablation of ventricular tachycardia
Wutzler, A., Mueller, A., Loehr, L., Huemer, M., Parwani, A. S., Attanasio, P., Blaschke, F., Storm, C., Boldt, L., & Haverkamp, W. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.175 · Cited by 25
“Despite the growing importance of catheter ablation in the treatment of VT [13,14] and an increasing number of procedures worldwide, only very few studies are available on procedural sedation and analgesia”
BackgroundKomatsu, Y., Maury, P., Sacher, F., Khairy, P., Daly, M. G., Lim, H. S., Zellerhoff, S., Jesel, L., Rollin, A., Duparc, A., et al. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12825 · Cited by 25
Aldhoon, B., Wichterle, D., Peichl, P., Cihak, R. J., & Kautzner, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171830 · Cited by 25
Pokorney, S. D., Friedman, D. J., Calkins, H. G., Callans, D. J., Daoud, E. G., Bella, P. E. D., JACKSON, K. P., Shivkumar, K., Saba, S., Sapp, J. L., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.04.001 · Cited by 24
On the Electrophysiology and Mapping of Intramural Arrhythmic Focus
Anderson, R. D., Padilla, J. R., Joens, C., Masse, S., Bhaskaran, A. P., Magtibay, K., Niri, A., Asta, J., Lai, P. F. H., Azam, M. A., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010384 · Cited by 24
Prasitlumkum, N., Navaravong, L., Desai, A., Desai, D. M., Cheungpasitporn, W., Rattanawong, P., Bunch, T. J., Jongnarangsin, K., & Chokesuwattanaskul, R. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.07.005 · Cited by 25
Self-citationŽižek, D., Mrak, M., Jan, M., Mežnar, A. Z., Ivanovski, M., Žlahtič, T., Kajdič, N., Antolič, B., Klemen, L., Skale, R., et al. (2024) · EP Europace · doi:10.1093/europace/euae109 · Cited by 24
“Considering the re-sults of the SMASH-VT study 6 we expected the preventive ablation to reduce the risk of receiving appropriate ICD therapy by 65%.”
MethodResultInfluentialPluta, S., Lenarczyk, R., Pruszkowska‐Skrzep, P., Kowalski, O., Sokal, A., Średniawa, B., Mazurek, M., & Kalarus, Z. F. (2010) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-009-9464-x · Cited by 24
“In patients with inducible VT after this procedure, linear ablation completely surrounding scar area and connecting it to a biological border (usually mitral annulus) was additionally performed [6, 7].”
BackgroundVaidya, V. R., DeSimone, C. V., Madhavan, M., Noheria, A., SHAHID, M., Walters, J., Ladewig, D. J., Mikell, S. B., Johnson, S. B., Suddendorf, S. H., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12437 · Cited by 24
Tereshchenko, L. G., Waks, J. W., Kabir, M., Ghafoori, E., Shvilkin, A. V., & Josephson, M. E. (2015) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2015.03.001 · Cited by 24
“Successful VT ablation can improve survival and quality of life, minimize or even eliminate the need for ICD therapies and/or toxic antiarrhythmic drugs [5,6], and decrease rates of heart failure (HF) hospitalizations.”
BackgroundSelf-citationPatel, D. R., Hasselblad, V., JACKSON, K. P., Pokorney, S. D., Daubert, J. P., & Al‐Khatib, S. M. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-0083-4 · Cited by 25
Epicardial Ablation With Irrigated Electrodes
Nagashima, K., Watanabe, I., Okumura, Y., Sonoda, K., Kofune, M., Mano, H., Ohkubo, K., Nakai, T., Kunimoto, S., Kasamaki, Y., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0984 · Cited by 24
Novel Mapping Strategies for Ventricular Tachycardia Ablation
Aziz, Z. A., & Tung, R. H. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0615-1 · Cited by 24
Carbucicchio, C., Jereczek-Fossa, B. A., Andreini, D., Catto, V., Piperno, G., Conte, E., Cattani, F., Rondi, E., Vigorito, S., Piccolo, C., et al. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00855-2 · Cited by 24
State of the art paper: Cardiovascular CT for planning ventricular tachycardia ablation procedures
Conte, E., Mushtaq, S., Carbucicchio, C., Piperno, G., Catto, V., Mancini, M. E., Formenti, A., Annoni, A. D., Guglielmo, M., Baggiano, A., et al. (2021) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2021.01.002 · Cited by 24
Proclemer, A., Dagres, N., Marinskis, G., Pison, L., Lip, G. Y. H., & Blomström‐Lundqvist, C. (2013) · EP Europace · doi:10.1093/europace/eus436 · Cited by 23
Claridge, S., Mennuni, S., Jackson, T., Behar, J. M., Porter, B., Sieniewicz, B., Bostock, J., O'Neill, M. D., MURGATROYD, F. D., Gill, J. S., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13226 · Cited by 23
Noninvasive cardiac arrhythmia ablation with particle beams
Graeff, C., & Bert, C. (2018) · Medical Physics · doi:10.1002/mp.12595 · Cited by 26
“Catheter ablation of the infarct scar can reduce the occurrence of cardiac shocks from the ICD.(6) Nevertheless, treatment of VT is even more challenging than of AF, as especially the left ventricular myocardium is often too thick to be penetrated completely by catheter ablation, even if performed intra- and epicardia…”
BackgroundKitamura, Τ., Martin, C., Vlachos, K. G., Martin, R. I. R., Frontera, A., Takigawa, M., Thompson, N. C., Cheniti, G., Massoullié, G., Lam, A., et al. (2019) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2019.100302 · Cited by 23
Jáuregui, B., Soto‐Iglesias, D., Zucchelli, G., Penela, D., Ordóñez, A., Teres, C. C., Chauca, A., Acosta, J., Fernández‐Armenta, J., Linhart, M., et al. (2020) · EP Europace · doi:10.1093/europace/euaa237 · Cited by 23
Maher, T. R., Freedman, B. L., Locke, A. H., Tracey, M., Waks, J. W., Litmanovich, D. E., & d’Ávila, A. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.05.018 · Cited by 22
Schleifer, J. W., & Srivathsan, K. S. (2013) · Cardiology Clinics · doi:10.1016/j.ccl.2013.07.007 · Cited by 27
Alzheimer?s disease: the impact of age-related changes in reproductive hormones
Atwood, C. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4380-4 · Cited by 25
Ventricular Tachycardia Ablation versus Antiarrhythmic-Drug Escalation
Sapp, J. L., Parkash, R., & Tang, A. S. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1610234 · Cited by 22
Vakil, K. P., Roukoz, H., Tung, R. H., Levy, W. C., Anand, I. S., Shivkumar, K., Rector, T. S., Vaseghi, M., & Tholakanahalli, V. N. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.09.008 · Cited by 21
Catheter ablation of electrical storm
Deneke, T., Lemke, B., Mügge, A., Shin, D., Grewe, P., Horlitz, M., Balta, O., Bösche, L., & Lawo, T. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.87 · Cited by 21
Management of Ventricular Arrhythmias in Patients with Mechanical Ventricular Support Devices
Healy, C., Viles-González, J. F., Sacher, F., Coffey, J. O., & d’Ávila, A. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0617-5 · Cited by 21
Takigawa, M., Noda, T., Kurita, T., Aihara, N., Yamada, Y., Okamura, H., Satomi, K., Suyama, K., Shimizu, W., & Kamakura, S. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0092 · Cited by 21
SKODA, J., Arya, A., Garcia, F. C., Gerstenfeld, E. P., Marchlinski, F. E., Hindricks, G., Miller, J. M., Petrů, J., Šedivá, L., Sha, Q., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12910 · Cited by 21
Self-citationNon-invasive Stereotactic Radioablation: A New Option for the Treatment of Ventricular Arrhythmias
Chen, W., Qian, P. C., Tedrow, U. B., Mak, R. H., & Zei, P. C. (2020) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.04 · Cited by 21
“Radiofrequency catheter ablation has emerged as an effective treatment for VT refractory to anti-arrhythmic therapy and has also been shown to reduce ICD shocks.(6,7) However, in the presence of structural heart disease, the long-term recurrence rate of ventricular arrhythmias has been shown to be greater than 50% acr…”
BackgroundDigital Twin–Guided Ablation for Ventricular Tachycardia
Chrispin, J., Prakosa, A., Kholmovski, E. G., Kolandaivelu, A., Barcelon, A., Aronis, K. N., Berger, R. D., Calkins, H. G., & Trayanova, N. A. (2026) · New England Journal of Medicine · doi:10.1056/nejmc2517822 · Cited by 20
Impact of ventricular tachycardia ablation on health care utilization
Winterfield, J. R., Kent, A. R., Karst, E., Dalal, N., Mahapatra, S., Bunch, T. J., Reynolds, M. R., & Wilber, D. J. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.009 · Cited by 22
Self-citationTzou, W. S., Rothstein, P., Cowherd, M., Zipse, M. M., TOMPKINS, C. M., Marzec, L., Aleong, R. G., Schuller, J. L., Varosy, P. D., Borne, R. T., et al. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13663 · Cited by 20
Lilli, A., Parollo, M., Mazzocchetti, L., Sensi, F. D., Rossi, A., Notarstefano, P., Santoro, A., Aquaro, G. D., Cresti, A., Lapira, F., et al. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02581-1 · Cited by 22
“Consequently, percutaneous ablation becomes an important approach to prevent VA occurrence [6, 7].”
BackgroundHuang, D. T.-C., Gošev, I., Wood, K. L., Vidula, H., Stevenson, W. G., Marchlinski, F., Supple, G. E., ZALAWADIYA, S. K., Weiss, J. P., Tung, R. H., et al. (2023) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.13073 · Cited by 20
“The SMASH– VT (Reddy et al., 2007) did not evaluate VTA burden as an endpoint.”
BackgroundActualización en cardiología geriátrica
Díaz-Castro, Ó., Datino, T., López‐Palop, R., & Martínez‐Sellés, M. (2011) · Revista Española de Cardiología · doi:10.1016/s0300-8932(11)70002-1 · Cited by 22
Chung, F., Lin, Y., Chang, S., Lo, L., Hu, Y., Chen, Y., Chiou, C.-W., & Chen, S. A. (2015) · Europe PMC (PubMed Central) · doi:10.6515/acs20140721a · Cited by 20
Liz, M. A., & Sousa, M. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4544-2 · Cited by 27
Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Waldo, A. L. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)06034-6 · Cited by 20
Substrate ablation of ventricular tachycardia in structural heart disease: a new dimension?
Bourke, J. P. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq357 · Cited by 20
Emerging Role of Digital Technology and Remote Monitoring in the Care of Cardiac Patients
Banchs, J. E., & Scher, D. M. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.02.013 · Cited by 22
Donahue, R. G., Lampert, R., Dornelas, E., Clemow, L., & Burg, M. M. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181c932d4 · Cited by 19
“Similar to previous studies of modalities to decrease ICD shocks (28), study participants are either new recipients of an ICD based on current guidelines or previous recipients of an ICD who have received appropriate ICD therapy (shock, antitachycardia pacing [ATP]) for a ventricular arrhythmia within the last 6 month…”
Epicardial catheter ablation for ventricular tachycardia in heparinized patients
Page, S. P., Duncan, E. R., Thomas, G., Ginks, M., Earley, M. J., Sporton, S. C., Dhinoja, M., & Schilling, R. (2012) · EP Europace · doi:10.1093/europace/eus258 · Cited by 19
Merchant, F. M., Hoskins, M. H., Benser, M. E., Roberts, G. J., Bastek, A. N., Knežević, A., Huang, Y., Langberg, J. J., León, A. R., & El‐Chami, M. F. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0386 · Cited by 20
Catheter Ablation of Cardiac Arrhythmias
Leong, F. T., & Mounsey, J. P. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0637-6.00033-7 · Cited by 19
Electrophysiologic Considerations After Sudden Cardiac Arrest
Suryanarayana, P. G., Garza, H.-H. K., Klewer, J., & Hutchinson, M. D. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x14666180507164443 · Cited by 19
“contemporaneous with ICD implantation) in patients with ischemic cardiomyopathy and spontaneous or inducible ventricular arrhythmias [57, 58].”
BackgroundCronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00664-2 · Cited by 19
Ventricular Arrhythmias in Patients With Implanted Defibrillators
Stevenson, W. G., & John, R. M. (2011) · Circulation · doi:10.1161/circulationaha.111.064816 · Cited by 20
Hayashi, T., Fukamizu, S., Hojo, R., Komiyama, K., Tanabe, Y., Tejima, T., Soejima, K., Nishizaki, M., Hiraoka, M., Ako, J., et al. (2013) · EP Europace · doi:10.1093/europace/eut050 · Cited by 19
“The Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) and the Ventricular Tachycardia Ablation in Coronary Heart Disease (VTACH) found that prophylactic catheter ablation (CA) reduces the incidence of appropriate ICD therapy in patients who had undergone ICD implantation as a me…”
BackgroundForty Years of Invasive Clinical Electrophysiology
Wellens, H. J. J. (2008) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.770529 · Cited by 24
Mahapatra, S., LaPar, D. J., Bhamidipati, C. M., McDaniel, G., Kamath, S., Bunch, T. J., & Ailawadi, G. (2011) · EP Europace · doi:10.1093/europace/eur017 · Cited by 18
“Recently, two trials suggested that ablation as first-line therapy is more effective than medical management for ischaemic VT with ICDs.(1,2) At the same time, current data also suggest that a significant proportion of patients with VT have circuits with epicardial components.”
BackgroundEfficacy of catheter ablation in patients with an electrical storm.
Koźluk, E., Gaj, S., Kiliszek, M., Lodziński, P., Piątkowska, A., & Opolski, G. (2011) · PubMed · Cited by 18
on behalf of MAGNETIC VT investigators, Biase, L. D., Tung, R. H., Szili‐Törok, T., Burkhardt, J. D., Weiss, P., Tavernier, R., Berman, A. E., Wißner, E., Spear, W., et al. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0217-3 · Cited by 18
Atti, V., Vuddanda, V. L. K., Turagam, M. K., Vemula, P., Shah, Z. I., Nagam, H., Yandrapalli, S., Jazayeri, M., Koerber, S. M., Gonzalez, J. V., et al. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0376-5 · Cited by 18
“Also, there were significant differences in Table 1 Baseline characteristics of included studies Study Design Study period Sample size Patient age mean ± SD (years) LVEF % Time since last MI (years) Follow-up (months) SMASH-VT 2007 RCT 2000–2006 PCA, 64; control, 64 PCA, 67 ± 9; control, 66 ± 10 PCA, 30.7 ± 9.5; contr…”
InfluentialMakimoto, H., Zielke, S., Clasen, L., Lin, T., Gerguri, S., Müller, P., Schmidt, J., Bejinariu, A., Kurt, M. M., Brinkmeyer, C., et al. (2020) · European journal of medical research · doi:10.1186/s40001-020-0401-x · Cited by 18
DRESEN, W. F., & Ferguson, J. (2017) · Cardiology Clinics · doi:10.1016/j.ccl.2017.08.007 · Cited by 18
Arrhythmias in Structural Heart Disease
Gillespie, H. S., Lin, C. C. H., & Prutkin, J. M. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0510-7 · Cited by 20
Metadata
- Authors
- Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-27
- Volume
- 357
- Issue
- 26
- Pages
- 2657-2665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2390777
- OpenAlex
- W2139803224
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 47 · 2023: 43 · 2022: 53 · 2021: 45 · 2020: 54 · 2019: 62 · 2018: 53 · 2017: 63 · 2016: 40 · 2015: 59 · 2014: 46 · 2013: 56 · 2012: 48
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL 68064, K23HL077171, K23HL068064)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, ventricular tachyarrhythmia, myocardial infarction, sudden cardiac death, radiofrequency ablation, substrate-based ablation, myocardial scar, ICD shocks, secondary prevention
- MeSH terms
- Aged, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Ventricular Fibrillation, Multivariate Analysis, Death, Sudden, Cardiac, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.